Circulating tumour DNA for precision medicine [ 1/1/2021 - 12/31/2025 ]

Research Grant

Brief description Many cancers shed small amounts of DNA (circulating tumour DNA or ctDNA) into the patient’s bloodstream. Recent technological advances now allow levels of ctDNA to be accurately measured in the blood. Changes in ctDNA levels have potential to be used as specific markers of disease progression and/or response to cancer therapy. This research will advance the use of ctDNA to serially follow patients and individualise treatment decisions in cancer management across several cancer types.

Funding Amount $1,544,066

Funding Scheme Investigator Grants

Chief Investigator Prof Sarah-Jane Dawson

Notes Leadership 1